Dyadic Logo Current.jpg
Dyadic to Present at Industry Events in November
October 30, 2023 08:30 ET | Dyadic International, Inc.
Dyadic to Present at Industry Events in November
Dyadic Logo Current.jpg
Dyadic to Report Third Quarter 2023 Financial Results on Wednesday, November 8, 2023
October 25, 2023 16:30 ET | Dyadic International, Inc.
JUPITER, Fla., Oct. 25, 2023 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company focused on building...
Dyadic Logo Current.jpg
Dyadic Appoints Doug Pace to Its Executive Leadership Team
October 09, 2023 08:30 ET | Dyadic International, Inc.
JUPITER, Fla., Oct. 09, 2023 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company focused on building...
22157.jpg
Global Human Nutrition Alternative Protein Ingredients Market Analysis Report 2023: B2B Market Dynamics of Plant Protein, Microbial Protein, and Insect Protein Ingredients
October 03, 2023 09:33 ET | Research and Markets
Dublin, Oct. 03, 2023 (GLOBE NEWSWIRE) -- The "Growth Opportunities in Alternative Protein Ingredients for Human Nutrition" report has been added to ResearchAndMarkets.com's offering. This...
Dyadic Logo Current.jpg
Dyadic to Present at Industry and Investor Events in October
September 29, 2023 08:30 ET | Dyadic International, Inc.
Dyadic to Present at Industry and Investor Events in October
Dyadic Logo Current.jpg
Dyadic Announces Development and License Agreement to Commercialize Animal-Free Alternative Proteins Using Dapibus™
September 19, 2023 08:00 ET | Dyadic International, Inc.
Dyadic to receive upfront payment of $0.6 million for product development and licensing its Dapibus™ platform, in addition to potential success fees, milestones, and royalties. JUPITER, Fla., Sept. ...
Dyadic Logo Current.jpg
Dyadic to Present at BioProcess International
September 12, 2023 16:30 ET | Dyadic International, Inc.
JUPITER, Fla., Sept. 12, 2023 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company focused on building innovative microbial...
Meticulous Logo.png
Edible Insects Market to Reach $16.39 Billion by 2032 - Exclusive Report by Meticulous Research®
August 24, 2023 09:00 ET | Meticulous Market Research Pvt. Ltd.
Redding, California, Aug. 24, 2023 (GLOBE NEWSWIRE) -- According to a new market research report titled, ‘Edible Insects Market by Product (Whole Insect, Insect Powder, Insect Meal, Insect Oil),...
Dyadic Logo Current.jpg
Dyadic Announces Second Quarter 2023 Financial Results and Highlights Recent Company Progress
August 09, 2023 16:00 ET | Dyadic International, Inc.
Positive Interim Phase 1 clinical trial safety results for C1 platform for manufacturing human vaccines Two MoU’s with Fondazione Biotecnopolo di Siena in Italy and Essential Drugs Company Limited...
Dyadic Logo Current.jpg
Dyadic Announces Continued Progress Towards Commercialization of Animal-Free Recombinant Serum Albumin
August 07, 2023 08:30 ET | Dyadic International, Inc.
JUPITER, Fla., Aug. 07, 2023 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company focused on building...